Gene · 23569
NIH grants1,778
NIH grants whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 1,778
Download this page as JSON| Grant | Title | PADI4 papers | Newest fiscal year |
|---|---|---|---|
| P30ES013508 | Center of Excellence in Environmental Toxicology | 2 | 2025 |
| P30EY011373 | CWRU NEI Vision Center Core Grant | 2 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 2 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 2 | 2025 |
| R01AR073201 | Bridging the gap between GWAS and mechanism in arthritis | 2 | 2025 |
| R01AR078268 | Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis | 2 | 2025 |
| R01AR081654 | Role of the L1 retrotransposon in interferon-positive SLE | 2 | 2025 |
| R01DE029709 | Osteoimmunology of Retarded Bone Regeneration in Periodontitis | 2 | 2025 |
| R01DE031206 | Trained innate immunity and periodontitis-associated comorbidities | 2 | 2025 |
| R01DK058110 | Dose-Dependent Effects of Hormone on the Activity of Estrogen Receptor Enhancers and Target Genes | 2 | 2025 |
| R01DK062357 | HuR/HIF – SIRT1 Signaling Axis in Liver Transplant Rejuvenation | 2 | 2025 |
| R01GM129325 | ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling | 2 | 2025 |
| R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 2 | 2025 |
| R01HL094601 | The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection | 2 | 2025 |
| R01HL101917 | Protease Activated Receptor and Thrombomodulin Signaling by coagulation proteases | 2 | 2025 |
| R01HL158601 | Regulatory roles of peptidylarginine deimination in elastogenisis | 2 | 2025 |
| R01NS118145 | Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS | 2 | 2025 |
| R35GM118097 | Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis | 2 | 2025 |
| R35GM119526 | Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma | 2 | 2025 |
| R35GM142963 | Role of vimentin in mammalian cell motility | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23569/grants?page=4